Learn More
Medchemexpress LLC Soticlestat | 1429505-03-2 | 99.83% | 373.45 | 10 MG

Supplier: Medchemexpress LLC HY109123100MG
Soticlestat (TAK-935; OV935) is a first-in-class, potent, selective, and orally active cholesterol 24-hydroxylase (CH24H) inhibitor with potential for epilepsy syndromes research.
- It is for research use only, not intended for human use.
- It inhibits the catalytic activity of human cholesterol 24-hydroxylase (CH24H) in a concentration-dependent manner with an IC50 of 4.5 nM.
- Treatment with soticlestat lowers brain 24S-hydroxycholesterol in a dose-dependent manner.
- It substantially reduces premature deaths of APP/PS1-Tg mice at a dose lowering brain 24S-hydroxycholesterol by approximately 50%.
- It can suppress potassium-evoked extracellular glutamate elevations in the hippocampus.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.